TOWA PHARMACEUTICAL
LIVE

Serial Number

87305763

Owner

TOWA PHARMACEUTICAL CO., LTD.

Attorney

Jeffrey H. Handelsman

First Use Date

Jan 1, 2017

Filing Date

Jan 18, 2017

Add to watchlist:

No watchlists yet
View on USPTO

TOWA PHARMACEUTICAL Trademark

Serial Number: 87305763 • Registration: 6136578

TOWA PHARMACEUTICAL is a trademark filed by TOWA PHARMACEUTICAL CO., LTD. on January 18, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

TOWA PHARMACEUTICAL CO., LTD. (8 trademarks)

Osaka 571-8580 , JP

Entity Type: 03

Trademark Details

Filing Date

January 18, 2017

Registration Date

August 25, 2020

First Use Anywhere

January 1, 2017

First Use in Commerce

January 1, 2019

Published for Opposition

November 28, 2017

Goods & Services

Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals(Based on 44(e)) Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals

Conducting early evaluations in the field of new pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 25, 2025 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 20, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 20, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 20, 2022 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Apr 20, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 20, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 20, 2022 COAR
REGISTERED-PRINCIPAL REGISTER
Aug 25, 2020 R.PR
AMENDMENT/PETITION AFTER APPROVAL FOR PUB ENTERED
Jul 20, 2020 AMPB
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 18, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 17, 2020 CNPR
NOTICE OF REVIVAL - E-MAILED
Jul 16, 2020 NREV
PETITION GRANTED - RESPONSE RECEIVED
Jul 16, 2020 PGRR
ASSIGNED TO PETITION STAFF
Jul 8, 2020 APET
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 11, 2020 TROA
TEAS PETITION TO REVIVE RECEIVED
May 11, 2020 PROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 4, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 4, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 4, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 4, 2020 REAP
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 1, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 1, 2020 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 17, 2019 GNFN
FINAL REFUSAL E-MAILED
Sep 17, 2019 GNFR
SU - FINAL REFUSAL - WRITTEN
Sep 17, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2019 CRFA
ASSIGNED TO LIE
Aug 29, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 24, 2019 GNRN
NON-FINAL ACTION E-MAILED
May 24, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 24, 2019 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 24, 2019 ZZZX
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 17, 2019 ERRR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 16, 2019 SUNA
ELECTRONIC RECORD REVIEW COMPLETE
May 15, 2019 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
May 10, 2019 ERRR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2019 EXRA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 7, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 6, 2019 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 5, 2019 SUPC
SOU EXTENSION 2 GRANTED
May 5, 2019 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 5, 2019 AITU
NOTICE OF REVIVAL - E-MAILED
Apr 24, 2019 NREV
USE AMENDMENT FILED
Apr 23, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 23, 2019 EISU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Apr 23, 2019 TPEX
PETITION TO REVIVE-GRANTED
Apr 23, 2019 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 23, 2019 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 25, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 25, 2019 ABN6
SOU EXTENSION 2 FILED
Jan 23, 2019 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jul 22, 2018 EX1G
SOU EXTENSION 1 FILED
Jul 22, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 22, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 23, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 28, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 28, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 8, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 19, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 17, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 17, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 18, 2017 GNRN
NON-FINAL ACTION E-MAILED
Apr 18, 2017 GNRT
NON-FINAL ACTION WRITTEN
Apr 18, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 13, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 25, 2017 NWOS
NEW APPLICATION ENTERED
Jan 21, 2017 NWAP